News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,472 Results
Type
Article (8052)
Company Profile (140)
Press Release (476375)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166760)
Career Advice (305)
Deals (25741)
Drug Delivery (7)
Drug Development (52878)
Employer Resources (14)
FDA (9760)
Job Trends (8574)
News (238211)
Policy (17910)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (485)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33155)
ALS (104)
Alzheimer's disease (974)
Antibody-drug conjugate (ADC) (262)
Approvals (10368)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (507)
Cancer (3628)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47848)
Collaboration (1239)
Commercialization (3)
Compensation (1449)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (737)
Cystic fibrosis (85)
Data (5625)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4178)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73676)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87584)
Executive appointments (697)
FDA (12367)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (910)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (289)
Government (941)
Grass and pollen (2)
Guidances (281)
Healthcare (9315)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (156)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (41)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (60)
Legal (5198)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (528)
Marketing (8)
MASH (118)
Medical device (8651)
Medtech (8791)
Mergers & acquisitions (14380)
Metabolic disorders (704)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1818)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (223)
Opinion (14)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (502)
Peanut (31)
People (41219)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15458)
Phase 2 (21369)
Phase 3 (14392)
Pipeline (7235)
Policy (18)
Postmarket research (1570)
Preclinical (6537)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3019)
Recruiting (6)
Regulatory (14792)
Reports (20)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Last 7 days (457)
Last 30 days (1609)
Last 365 days (19025)
2026 (12075)
2025 (19251)
2024 (22987)
2023 (26540)
2022 (34595)
2021 (37180)
2020 (33483)
2019 (23257)
2018 (17469)
2017 (18767)
2016 (17919)
2015 (24264)
2014 (21681)
2013 (18140)
2012 (20226)
2011 (20444)
2010 (20333)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17883)
Australia (2097)
California (11905)
Canada (3127)
China (517)
Colorado (481)
Connecticut (407)
Delaware (207)
Europe (24623)
Florida (1780)
Georgia (375)
Hawaii (3)
Idaho (46)
Illinois (695)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1193)
Massachusetts (7825)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2610)
New Mexico (12)
New York (2811)
North Carolina (1267)
North Dakota (4)
Northern California (5961)
Ohio (276)
Oklahoma (14)
Oregon (16)
Pennsylvania (2244)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4942)
Tennessee (119)
Texas (1925)
United States (38673)
Utah (358)
Vermont (1)
Virginia (152)
Washington D.C. (38)
Washington State (921)
West Virginia (1)
Wisconsin (73)
484,472 Results for "plexxikon inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Policy
Judge Orders Novartis to Cough Up $178 Million to Plexxikon Over Patent Infringements
Novartis claimed the patents held by Plexxikon were invalid. Unfortunately for the company, the jury found it was unable to prove these claims.
July 23, 2021
·
2 min read
·
Brandon May
Business
Novellus Executes Exclusive Worldwide License Agreement with Plexxikon for PLX8394, Plexxikon’s Next-Generation, Clinical Stage BRAF Inhibitor
Novellus, a precision-oncology drug development company, announced today that it has entered into an exclusive worldwide license agreement with Plexxikon, a member of the Daiichi Sankyo Group, for PLX8394, its clinical-stage oncology drug candidate which targets the BRAF protein. PLX8394 is currently completing a Ph
June 3, 2020
·
3 min read
Policy
Daiichi Sankyo Reaches $182M Settlement with Novartis in Tafinlar Patent Case
Plexxikon, which was acquired by Daiichi Sankyo, and Novartis have agreed to settle a patent case involving the cancer drug Tafinlar and its sale in the U.S.
December 8, 2023
·
1 min read
·
Tyler Patchen
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Press Releases
Biogen Completes Acquisition of RayThera Inc.
August 7, 2026
·
7 min read
Press Releases
Therma Bright Inc. Completes Debt Settlements
July 30, 2026
·
3 min read
Business
Plexxikon Announces Key Executive Appointments; Dr. Chao Zhang Named Chief Executive Officer and Marguerite Hutchinson, JD, Named Chief Operating Officer
Plexxikon, a member of the Daiichi Sankyo Group and a leader in structure-guided discovery and development of novel small molecule pharmaceuticals, today announced that Chao Zhang, PhD, has been promoted to chief executive officer from chief scientific officer.
July 1, 2021
·
4 min read
Press Releases
Utah Medical Products, Inc. Announces Quarterly Dividend
August 4, 2026
·
1 min read
Press Releases
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
August 5, 2026
·
3 min read
1 of 48,448
Next
